Gastrointestinal effects: the main titration bottleneck Nausea, diarrhea, constipation, and vomiting run around 40 to 44% overall, dose-dependent in how many people report them but mild-dominant in severity: severe events stay at or below about 1.7% in any category even at the top dose. In the obesity program the by-dose rates run nausea 25/29/28%, diarrhea 19/21/23%, and vomiting 8/11/13% at 5/10/15 mg. They concentrate during escalation and ease with time on a held dose
By promoting angiogenesis and collagen production, it helps rebuild tissues faster and more efficiently
It has been studied for tissue repair and inflammation in many animal models
Step 6: Label and store Write the date of reconstitution, the concentration (5mg/mL or 10mg/mL), and the vial contents on a small label or directly on the vial with a marker
For mild, diet-related low levels, tablets can be equally effective